Overview

Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease

Status:
Terminated
Trial end date:
2014-01-02
Target enrollment:
Participant gender:
Summary
The study was designed to evaluate the use of ETT electrocardiogram (ECG) indices as biomarkers in the assessment of atherosclerotic coronary vascular disease (ASCVD).
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Ranolazine